Showing results (11-20 of 90) with videos related to
Sort By:
Pageof 9
Cancer|July 15, 2024
Out-of-pocket costs for diagnostic testing following abnormal prostate cancer screening among privately insured menArnav Srivastava, Anca Tilea, David D Kim, et al.Urology Case Reports|September 22, 2017
Patient with antiphospholipid syndrome presenting with testicular torsion-like symptomsArnav Srivastava, Joan Ko, Joy Ogunsile, et al.The Journal of Clinical Ethics|May 25, 2023
Survey of Informed Consent Procedures in Urology: Disclosing Resident Participation to PatientsJuliana E Kim, Labeeqa Khizir, Arnav Srivastava, et al.Cancers|June 10, 2022
New Paradigms for Cytoreductive NephrectomyBenjamin J Lichtbroun, Arnav Srivastava, Sai Krishnaraya Doppalapudi, et al.Current Opinion in Oncology|March 10, 2022
The roaring 2020s: a new decade of systemic therapy for renal cell carcinomaArnav Srivastava, Sai K Doppalapudi, Hiren V Patel, et al.Urologic Oncology|July 2, 2025
Concordance between clinical and pathologic staging of larger (cT2a-b) and more invasive (cT3a) renal cell carcinomaTaylor Goodstein, Rajvi Goradia, Arnav Srivastava, et al.Current Urology Reports|January 6, 2021
From Diagnosis to Therapy-PET Imaging for Pheochromocytomas and ParagangliomasHiren V Patel, Arnav Srivastava, Murray D Becker, et al.Clinical Genitourinary Cancer|September 17, 2025
Impact of Upstaging From cT2a-b to pT3a on Overall Survival Among Patients With Renal Cell CarcinomaTaylor Goodstein, Rajvi Goradia, Arnav Srivastava, et al.Urology|January 11, 2021
The Feasibility and Efficacy of a Multi-Institutional Urology Boot Camp for Incoming Urology ResidentsAlexandra L Tabakin, Priya J Dave, Arnav Srivastava, et al.Urology|November 22, 2021
Disparities in the Treatment and Survival of Metastatic Renal Cell CarcinomaMeredith R Metcalf, Vanessa N Peña, Joseph G Cheaib, et al.Pageof 9